Sunday, November 8, 2026

USD/EUR Over 2% Down In The Last 21 Sessions

ViaNews Editorial Team

February 2, 2023

USD/EUR Over 2% Down In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 2.17% for the last 21 sessions. At 16:10 EST on Thursday, 2 February, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 5.31% up from its 52-week low and 12.593% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a positive 0.15%, a negative 0.09%, and a positive 0.52%, respectively.

USD/EUR's highest amplitude of average volatility was 0.19% (last week), 0.42% (last month), and 0.52% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be oversold (<=20).

News about

  • Usd/jpy price analysis: bears eye a test of 130.00 pre federal reserve. According to FXStreet on Tuesday, 31 January, "Meanwhile, the US Dollar rose on Monday, ahead of the Federal Reserve'stwo-day policy meeting which is likely to keep traders at bay and USD/JPY range bound until the outcome of the meeting. "
  • Usd/jpy portrays pre-fed anxiety, boj’s struggle to defend JGB yields around 130.00. According to FXStreet on Wednesday, 1 February, "It should be noted that downbeat US Treasury bond yields joined and firmer equity earnings and softer US data to renew the US Dollar weakness and strengthened the USD/JPY pullback.", "Looking ahead, multiple PMIs from China, Eurozone and the US may entertain the USD/JPY traders, as well as the JGB moves. "
  • Usd/jpy bulls hesitate around mid-130.00s as upbeat Japan data tease boj hawks. According to FXStreet on Tuesday, 31 January, "A daily closing beyond the 21-DMA level surrounding 130.35, the first early November 2021, keeps USD/JPY buyers hopeful.", "Additionally, China's inability to spread optimism after returning from the one-week-old Lunar New Year holiday, even with hopes of witnessing an end to the Covid wave, also favored the USD/JPY buyers."
  • Usd/jpy bulls hesitate around mid-130.00s as upbeat Japan data tease boj hawks. According to FXStreet on Tuesday, 31 January, "It should be noted that the cautious risk profile before the equity heavyweights like Amazon, Alphabet, Apple and Metal release their quarterly earnings, also underpinned the USD/JPY run-up the previous day.", "Additionally, China's inability to spread optimism after returning from the one-week-old Lunar New Year holiday, even with hopes of witnessing an end to the Covid wave, also favored the USD/JPY buyers."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com